Business

In a groundbreaking advisory issued by Dr. Vivek Murthy, the U.S. Surgeon General, the alarming link between alcohol consumption and various types of cancer has been underscored, pressing society to confront an often-overlooked public health crisis. Notably, the advisory points to a clear correlation between alcohol intake and at least seven types of cancer, including
0 Comments
In a provocative report released by Hindenburg Research, the short-selling firm has taken aim at Carvana, the online used-car retailer, claiming that the company’s recent financial resurgence is deceptive and fundamentally unsustainable. Hindenburg argues that Carvana’s recovery is akin to a “mirage,” sustained by questionable financial practices including unstable loan sales and alleged accounting manipulations.
0 Comments
The year 2024 has proven to be a tumultuous one for the restaurant industry, particularly affecting casual dining chains that have seen a significant decline in patronage. As inflation impacts consumer spending, many people are reevaluating their dining habits, gravitating towards more affordable options or staying in altogether. Data from Black Box Intelligence highlights a
0 Comments
Christmas this year brought an unexpected yet delightful surprise for sports enthusiasts, particularly through the lens of streaming services. As millions gathered around their screens to enjoy the festive cheer, Netflix and its exclusive airing of NFL games captured the attention and affection of a record-breaking audience. With nearly 65 million viewers tuning in, it
0 Comments
The recent complaint filed by the Consumer Financial Protection Bureau (CFPB) against retail giant Walmart and the work-scheduling platform Branch Messenger has ignited a significant debate in the realm of worker rights and financial ethics. This legal action underscores a troubling trend where large corporations are accused of taking advantage of their workers, particularly in
0 Comments
Eli Lilly has recently made headlines with the Food and Drug Administration’s (FDA) approval of Zepbound, a groundbreaking treatment for individuals suffering from moderate-to-severe obstructive sleep apnea (OSA). The drug, previously recognized for its weight-loss capabilities, now expands its therapeutic scope to include one of the most prevalent sleep disorders in the United States. OSA
0 Comments